Cornelia Kamp, M.B.A.

Cornelia Kamp, M.B.A.

Contact Information

Center for Human Experimental Therapeutics
Box CU 420694
265 Crittenden Blvd
Rochester, NY 14642

Journal Articles

Showing all 23 journal articles available.

2011
Dworkin, RH, Turk, TC, Katz, NP, Rowbotham MP, Peirce-Sandner S, Cerny I, Clingman CS, Farrar JT, Kamp C, McDermott MP, Rappaport BA, Sandia WS. "Evidence-based clinical trial design for chronic pain pharmacotherapy: A blueprint for ACTION". Pain. 2011; .
2009
Dworkin, R.; Barbano, R.; Tyring, S.; Betts, R.; McDermott, M.; Pennella-Vaughan, J.; Bennett, G.; Berber, E.; Gnann, J.; Irvine, C.; Kamp, C.; Kieburtz, K.; Max, M.; Schmader, K. "A Randomized, Placebo-Controlled Trial of Oxycodone and of Gabapentin for Acute Pain in Herpes Zoster." Pain. 2009; 142: 209-217.
2008
The NINDS NET-PD Investigators (Galpern, W.; MD, primary author). "A Pilot Clinical Trial of Creatine and Minocycline in Early Parkinson Disease: 18-Month Results." Clinical Neuropharmacology. 2008; 31: 141-150.
2007
Parkinson Study Group (Tanner, CM.; primary author). "Pramipexole in Levodopa Treated Parkinson's Disease Patients of African, Asian and Hispanic heritage." Clinical Neuropharmacology. 2007; 30 (2): 72-85.
2007
The NINDS NET-PD Investigators (Kieburtz, K.; Primary author). "A Randomized Clinical Trial of Coenzyme Q10 and GPI-1485 in Early Parkinson's Disease." Neurology. 2007; 68: 20-28.
2006
The NINDS NET-PD Investigators, NET-PD Steering Committee. "A randomized, double-blind, futility clinical trial of creatine and minocycline in early Parkinson's disease." Neurology. 2006; 66: 664-671.
2006
Parkinson Study Group (Karen Blindauer, primary author). "Randomized placebo-controlled study of the nicotinic agonist, 51B-15084 in Parkinson's disease." Neurology. 2006; 66: 408-410.
2005
Parkinson Study Group (Steven Schwid, primary author). "A Randomized Placebo-Controlled Trial of Rasagiline in Levodopa-Treated Patients with Parkinson Disease and Motor Fluctuations." Arch Neurol. 2005; 62: 241-248.
2005
Elm J, Goetz C, Ravina B, Shannon K, Wooten F, Tanner C, Palesch Y, Huang P, Guimaraes P, Kamp C, Tilley B, Kieburtz K, for the NET-PD Investigators. "A Responsive Outcome for Parkinson's Disease Neuroprotection Futility Studies." Annals of Neurology. 2005; 57(2): 197-203.
2005
Comella CL, Jankovic J, Shannon KM, et al. "A Comparison of botulinum toxin serotypes A and B for the treatment of Cervical Dystonia." Neurology. 2005; 65: 1423-1429.
2004
Parkinson Study Group (Steven Schwid, primary author). "The safety and tolerability of a mixed lineage kinase inhibitor (CEP-1347) in PD." Neurology. 2004; 62: 330-332.
2004
Parkinson Study Group (Robert Holloway, primary author). "Pramipexole vs levodopa as initial treatment for Parkinson disease: A 4-year Randomized Controlled Trial." Arch Neurol. 2004; 61(7): 1044-1053.
2004
Noyes K, Dick A, Holloway RG, and the Parkinson Study Group. "Pramipexole vs Levodopa as Initial Treatment for Parkinson's Disease. A Randomized Clinical-economic Trial." Med Decis Making. 2004; 2004: 472-485.
2004
Holloway, RG.; Shouldson, I.; Fahn, S.; Kieburtz, K.; Lang, A.; Marek, K.; McDermott, M.; Seibyl, J.; Weiner, W.; Musch, B.; Kamp, C.; et. al..; Parkinson Study Group. "Pramipexole vs levodopa as initial treatment for Parkinson disease: a 4-year randomized controlled trial." Arch Neurol. 2004; 61(7): 1044-53.
2003
Parkinson Study Group (Karen Blindauer, primary author). "A Controlled Trial of rotigotine Monotherapy in Early Parkinson's Disease." Arch Neurol. 2003; 60: 1721:1728.
2002
Parkinson Study Group (Kenneth Marek, primary author). "Dopamine Transporter Brain Imaging to Assess the Effects of Pramipexole vs Levodopa on Parkinson Disease Progression." JAMA. 2002; 287 (13): 1653-1661.
2000
Sacktor, N.; Schifitto, G.; McDermott, MP.; Marder, K.; McArthur, JC.; Kieburtz, K. "Transdermal selegiline in HIV-associated cognitive impairment: Pilot, placebo-controlled study." Neurology. 2000; 54: 233-235.
2000
Parkinson Study Group (Holloway R, primary author). "Pramipexole vs levodopa as initial treatment for Parkinson disease. A randomized controlled trial." JAMA. 2000; 284: 1931-1938.
2000
Parkinson Study Group. "A randomized controlled trial comparing pramipexole with levodopa in early Parkinson's disease: Design and methods of the CALM-PD study." Clinical Neuropharmacology. 2000; 23: 34-44.
1999
Schifitto, G.; Sacktor, N.; Marder, K.; McDermott, M.; McArthur, JC.; Kieburtz , K.; et al. "Randomized trial of the PAF antagonist lexipafant in HIV-associated cognitive impairment." Neurology. 1999; 53: 391-396.
1998
The Dana Consortium on the Therapy of HIV Dementia and Related Cognitive Disorders (N Sacktor, primary author). "A randomized, double-blind, placebo-controlled trial of deprenyl and thioctic acid in human immunodeficiency virus-associated cognitive impairment." Neurology. 1998; 50: 645-651.
1993
Rifai, Z.; Kazee, AM.; Kamp, C.;, Griggs, RC. "Intranuclear rods in severe congenital nemaline myopathy." Neurology. 1993; 43: 2372-2377.
0
Schwid SR, Bausch J, Oakes D, Schuchter L, Tanner C, Forrest M, Lang AE, Shoulson I and the PSG PRECEPT Investigators. "Cancer incidence in a trial of an anti-apoptotic agent for Parkinson's Disease." Mov Dis. .

Books

2010
Ravina B, Cummings J, McDermott M, Poole M, Kamp C, Germain JM. "Study Conduct: Academic and Industry Perspectives". Clinical Trials in Neurology: From Idea to Implementation. : Cambridge University Press, 2010.
2002
Dunn C, Chadwick G, Kamp C, Shinaman A. "Participant Recruitment and Retention in Clinical Trials". Protecting Study Volunteers in Research: A Manual for Investigative Sites. Sara Gambrill. Boston: Ken Getz, 2002. 141-149